192 related articles for article (PubMed ID: 12934099)
61. Inhibition of JAK kinase activity enhances Fas-mediated apoptosis but reduces cytotoxic activity of topoisomerase II inhibitors in U266 myeloma cells.
Oshiro MM; Landowski TH; Catlett-Falcone R; Hazlehurst LA; Huang M; Jove R; Dalton WS
Clin Cancer Res; 2001 Dec; 7(12):4262-71. PubMed ID: 11751528
[TBL] [Abstract][Full Text] [Related]
62. Activation status of the JAK/STAT3 pathway in mantle cell lymphoma.
Yared MA; Khoury JD; Medeiros LJ; Rassidakis GZ; Lai R
Arch Pathol Lab Med; 2005 Aug; 129(8):990-6. PubMed ID: 16048411
[TBL] [Abstract][Full Text] [Related]
63. The anaplastic lymphoma kinase controls cell shape and growth of anaplastic large cell lymphoma through Cdc42 activation.
Ambrogio C; Voena C; Manazza AD; Martinengo C; Costa C; Kirchhausen T; Hirsch E; Inghirami G; Chiarle R
Cancer Res; 2008 Nov; 68(21):8899-907. PubMed ID: 18974134
[TBL] [Abstract][Full Text] [Related]
64. Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells.
Eriksen KW; Kaltoft K; Mikkelsen G; Nielsen M; Zhang Q; Geisler C; Nissen MH; Röpke C; Wasik MA; Odum N
Leukemia; 2001 May; 15(5):787-93. PubMed ID: 11368440
[TBL] [Abstract][Full Text] [Related]
65. The oncogenic JUNB/CD30 axis contributes to cell cycle deregulation in ALK+ anaplastic large cell lymphoma.
Atsaves V; Lekakis L; Drakos E; Leventaki V; Ghaderi M; Baltatzis GE; Chioureas D; Jones D; Feretzaki M; Liakou C; Panayiotidis P; Gorgoulis V; Patsouris E; Medeiros LJ; Claret FX; Rassidakis GZ
Br J Haematol; 2014 Nov; 167(4):514-23. PubMed ID: 25145835
[TBL] [Abstract][Full Text] [Related]
66. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
67. Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK.
Uchihara Y; Ueda F; Tago K; Nakazawa Y; Ohe T; Mashino T; Yokota S; Kasahara T; Tamura H; Funakoshi-Tago M
PLoS One; 2017; 12(8):e0183003. PubMed ID: 28806414
[TBL] [Abstract][Full Text] [Related]
68. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G
Blood; 2003 Mar; 101(5):1919-27. PubMed ID: 12424201
[TBL] [Abstract][Full Text] [Related]
69. Jak3 contributes to the activation of ALK and Stat3 in ALK(+) anaplastic large cell lymphoma.
Amin HM; Lin Q; Lai R
Lab Invest; 2006 Apr; 86(4):417-9; author reply 420-1. PubMed ID: 16554750
[No Abstract] [Full Text] [Related]
70. Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma.
Uddin S; Hussain AR; Manogaran PS; Al-Hussein K; Platanias LC; Gutierrez MI; Bhatia KG
Oncogene; 2005 Oct; 24(47):7022-30. PubMed ID: 16044161
[TBL] [Abstract][Full Text] [Related]
71. Sensitivity Analysis of the NPM-ALK Signalling Network Reveals Important Pathways for Anaplastic Large Cell Lymphoma Combination Therapy.
Buetti-Dinh A; O'Hare T; Friedman R
PLoS One; 2016; 11(9):e0163011. PubMed ID: 27669408
[TBL] [Abstract][Full Text] [Related]
72. Expression levels of apoptosis-related proteins predict clinical outcome in anaplastic large cell lymphoma.
ten Berge RL; Meijer CJ; Dukers DF; Kummer JA; Bladergroen BA; Vos W; Hack CE; Ossenkoppele GJ; Oudejans JJ
Blood; 2002 Jun; 99(12):4540-6. PubMed ID: 12036886
[TBL] [Abstract][Full Text] [Related]
73. Dependence of peripheral T-cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach.
Le K; Vollenweider J; Han J; Staudinger N; Stenson M; Bayraktar L; Wellik LE; Maurer MJ; McPhail ED; Witzig TE; Gupta M
Hematol Oncol; 2024 Jan; 42(1):e3233. PubMed ID: 37876297
[TBL] [Abstract][Full Text] [Related]
74. Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation.
Tibbles HE; Vassilev A; Wendorf H; Schonhoff D; Zhu D; Lorenz D; Waurzyniak B; Liu XP; Uckun FM
J Biol Chem; 2001 May; 276(21):17815-22. PubMed ID: 11278899
[TBL] [Abstract][Full Text] [Related]
75. Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.
Prutsch N; Gurnhofer E; Suske T; Liang HC; Schlederer M; Roos S; Wu LC; Simonitsch-Klupp I; Alvarez-Hernandez A; Kornauth C; Leone DA; Svinka J; Eferl R; Limberger T; Aufinger A; Shirsath N; Wolf P; Hielscher T; Sternberg C; Aberger F; Schmoellerl J; Stoiber D; Strobl B; Jäger U; Staber PB; Grebien F; Moriggl R; Müller M; Inghirami GG; Sanda T; Look AT; Turner SD; Kenner L; Merkel O
Leukemia; 2019 Mar; 33(3):696-709. PubMed ID: 30131584
[TBL] [Abstract][Full Text] [Related]
76. STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis.
Holtick U; Vockerodt M; Pinkert D; Schoof N; Stürzenhofecker B; Kussebi N; Lauber K; Wesselborg S; Löffler D; Horn F; Trümper L; Kube D
Leukemia; 2005 Jun; 19(6):936-44. PubMed ID: 15912144
[TBL] [Abstract][Full Text] [Related]
77. Pyrimidine tract-binding protein 1 mediates pyruvate kinase M2-dependent phosphorylation of signal transducer and activator of transcription 3 and oncogenesis in anaplastic large cell lymphoma.
Hwang SR; Murga-Zamalloa C; Brown N; Basappa J; McDonnell SR; Mendoza-Reinoso V; Basrur V; Wilcox R; Elenitoba-Johnson K; Lim MS
Lab Invest; 2017 Aug; 97(8):962-970. PubMed ID: 28414323
[TBL] [Abstract][Full Text] [Related]
78. Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase.
Bacchiocchi R; Baldanzi G; Carbonari D; Capomagi C; Colombo E; van Blitterswijk WJ; Graziani A; Fazioli F
Blood; 2005 Sep; 106(6):2175-82. PubMed ID: 15928040
[TBL] [Abstract][Full Text] [Related]
79. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.
Aoki Y; Feldman GM; Tosato G
Blood; 2003 Feb; 101(4):1535-42. PubMed ID: 12393476
[TBL] [Abstract][Full Text] [Related]
80. Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma.
Mura G; Karaca Atabay E; Menotti M; Martinengo C; Ambrogio C; Giacomello G; Arigoni M; Olivero M; Calogero RA; Chiarle R; Voena C
Front Oncol; 2022; 12():1085672. PubMed ID: 36698412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
